Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov/Dec;29(6):387-393.
doi: 10.5830/CVJA-2017-039.

Pre-eclampsia and the foetus: a cardiovascular perspective

Affiliations
Review

Pre-eclampsia and the foetus: a cardiovascular perspective

Ismail Bhorat. Cardiovasc J Afr. 2018 Nov/Dec.

Abstract

Pre-eclampsia is the leading cause of perinatal morbidity and mortality. A full understanding of the pathogenesis of this enigmatic condition is essential if we are to develop new prophylactic and therapeutic interventions. Central to our understanding of the pathogenesis of early-onset preeclampsia is absolute utero-placental ischaemia, which is lack of placental vascular transformation in early pregnancy. By contrast, relative utero-placental ischaemia, due to a mismatch between utero-placental blood flow and increased demand for nutrients occurring later in pregnancy, may be central to the development of late-onset pre-eclampsia. These pathogenic mechanisms have advanced our understanding of this condition, leading to better prediction, screening and intervention modalities. Screening for pre-eclampsia in the first and second trimesters by investigating the maternoplacental circulation and placental hormones could identify a high-risk subgroup. The advantage of screening in the first trimester is that a prophylactic intervention is available in the form of low-dose aspirin, if started before 16 weeks' gestation in the high-risk group, resulting in a substantial reduction in severe early-onset pre-eclampsia, while identification of a high-risk group in the second trimester will lead to focused management in this group. Using a combination of cardiac Doppler, multi-vessel Doppler assessment of the foetal circulation and biomarkers in established pre-eclampsia in the third trimester could predict adverse outcomes and guide clinicians to timeous delivery. Hopefully, advances in our understanding of this enigmatic disease will lead to further prophylactic and new therapeutic interventions.

Keywords: Doppler of foetal circulation; cardiac Doppler; foetus; placental hormones; pre‐eclampsia; utero‐placental ischaemia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A clinical algorithm using sonography and Doppler to track the cascade of cardiovascular deterioration of the foetus in pre-eclampsia. AC = abdominal circumference, EWF = expected foetal weight, IUGR = intrauterine growth restriction, SGA = small for gestational age, DV = ductus venosus, CTG = cardiotocography, BPP = biophysical profile, PI = pulsatility index, MPI = myocardial performance index.

Similar articles

Cited by

References

    1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–1074. - PubMed
    1. WHO guidelines approved by the guidelines committee. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. World Health Organisation: Geneva, 2011 - PubMed
    1. American College of Obstetricians and Gynaecologists; task force on hypertension in pregnancy. Report of the American College of Obstetricians and Gynaecologists task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–1131. - PubMed
    1. Magee LA, Pels A, Helewa M, Rey E, von Dadelzen P. SOGC hypertension guideline committee. Diagnosis, evaluation and management of hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36:416–441. - PubMed
    1. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W. et al. The classification, diagnosis and management of hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4:97–104. - PubMed